Physician profile
Atsushi Yoshida
NPI 1104989730
$219,450.06
in general payments reported to CMS, 2019-2025
7 companies · $62K in 2025
The $62K reported for 2025 was more than what 98% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $37K · 2021: $21K · 2022: $39K · 2023: $15K · 2024: $18K · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $56K · Travel and Lodging: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,500 · Food and Beverage: $4,907 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $56,113.44 |
| Travel and Lodging | $26,027.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,500.00 |
| Food and Beverage | $4,907.29 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $210,980.27 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Transmedics, INC. | $5,570.79 | 2023-2025 | Organ Care System |
| Histosonics, INC. | $2,356.29 | 2025 | |
| Intera Oncology, INC | $147.19 | 2025 | Intera |
| Ethicon US, LLC | $141.40 | 2023-2025 | Enseal, Harmonic, Echelon; Endopath |
| Medtronic, INC. | $131.24 | 2025 | Emprint |
| Novartis Pharmaceuticals Corporation | $122.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atsushi Yoshida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.